Pipeline Therapeutics pulls in $80m Series C
Pipeline Therapeutics, a biopharmaceutical company, has secured $80 million in Series C financing.
Pipeline Therapeutics, a biopharmaceutical company, has secured $80 million in Series C financing.
Copyright PEI Media
Not for publication, email or dissemination
